SLT Glaucoma Treatment
SLT laser therapy uses short pulses of low-energy light, selectively targeting cells that don't drain well, while preserving the surrounding tissue. Traditional therapies cause some amount of coagulative damage, or clotting, within the trabecular meshwork of the eye, but SLT does not – allowing for multiple treatments to lower eye pressure.

Among national clinical trials, Coherent Medical Group, the manufacturer of the SLT laser, conducted a multi-center, prospective clinical study to evaluate its effectiveness. At 26 weeks post-SLT, there was a significant decrease in intraocular pressure as compared to the baseline pressure.

 Since the physicians at Grossnickle Eye Center have begun using the SLT laser, we have noted average drop in intraocular pressure of 4-5 mm Hg.